Darryl S. Inaba, PharmD.
Director of Clinical and Behavioral Health Services
Addictions Recovery Center
Darryl S. Inaba, PharmD, CATC V, CADC III Director of Clinical and Behavioral Health Service, Addictions Recovery Center, Medford Oregon and Director of Research and Education at CNS Productions, Inc. in Medford Oregon.
Dr. Inaba is a Lifetime Fellow at Haight Ashbury Free Clinics in San Francisco and Associate Clinical Professor of Pharmacy at the University of California San Francisco School of Pharmacy. While working at the Haight-Ashbury Clinics, Dr. Inaba supervised the clinical treatment of over 300,000 self-referred substance abusers. He is noted for his work in developing culturally consistent treatment services with the National Asian Pacific American Families Against Substance Abuse and the Glide Memorial Church’s African American Extended Family Recovery Center in San Francisco.
Additionally, Dr. Inaba has served on numerous boards and commissions and has received over 90 individual awards of merit including awards from the California Society of Addiction Medicine and the California Association of County Drug Program Administrators. He earned a Doctor of Pharmacy from the University of California, San Francisco School of Pharmacy in 1971 and is a Certified Addiction Treatment Counselor (CATC) Level V and a Certified Alcohol and Drug Counselor III.
Dr. Inaba is the author of several publications and award winning educational videos on all aspects of substance abuse work. He and Mr. William Cohen co-authored Uppers, Downer, All Arounders that is used as the principal text on substance use disorders in over 400 U.S. universities and has been translated in over 6 foreign languages. The publication is now in its 8th Edition published in 2014.
Presentation information is being cultivated. Please check back soon.
DAY 2 PLENARY
Current Trends in Stimulant Use Disorders: Pharmacology & Treatment
Amid the staggering COVID-19 Pandemic, we are still suffering from an even greater endemic of addiction and overdose deaths. Though media has focused on opioid abuse, methamphetamine, cocaine, benzodiazepine and alcohol abuse and overdose deaths have increased in the past few years. This presentation will focus on the current situation with Stimulant Use Disorder. Current trends in the abuse of substances, new forms of abuse, the pharmacology and developments in treatment will be presented. Participation in this virtual presentation will provide one with a better awareness the problems and consequences that result from stimulant drug abuse and addiction, especially cocaine and methamphetamine. Participants will also be able to identify the unique pharmacology of “Ice” = dextro-isomer methamphetamine as well as the major toxic symptoms that result from its abuse. Current treatment approaches for this addiction will also be reviewed and discussed.
At the completion of this presentation, a participant will be able to:
Identify at least 3 current street names for dextro-isomer methamphetamine and cocaine
Name 4 major toxic reactions that occur as a result of methamphetamine and cocaine abuse
Recognize at least 4 major intrauterine and developmental risk concerns regarding the abuse of methamphetamine during pregnancy
List 4 major toxic and withdrawal processes of methamphetamine and cocaine abuse V. Discuss the phases of stimulant use disorder treatment and some current treatment approaches
This workshop is approved for 1-hour Renewal Credit/CEU for: IC&RC/NJ-AP Certification Board | NAADAC | DOE | NASW-NJ [Clinical credit]